| Bid Price | 412.50p | High Price | 416.28p |
|---|
| Ask Price | 416.50p | Low Price | 400.50p |
|---|
| Open Price | 400.50p | Spread | 0.96% |
|---|
| Prev Close | 412.50p | Volume | 127,284 |
|---|
Oxford Biomedica PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 20, 2024 | 415.00 | 418.00 | 410.00 | 412.50 | 331,014 |
| Nov 19, 2024 | 406.50 | 414.50 | 403.00 | 412.50 | 135,235 |
| Nov 18, 2024 | 390.00 | 412.70 | 390.00 | 410.00 | 352,884 |
| Nov 15, 2024 | 396.00 | 416.50 | 395.00 | 409.00 | 397,534 |
| Nov 14, 2024 | 401.50 | 428.00 | 390.00 | 412.50 | 253,122 |
Oxford Biomedica PLC Information
| Name | Oxford Biomedica PLC | Index | FTSE All Share |
|---|
| ISIN | GB00BDFBVT43 | Epic | OXB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSMM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Post Trading |
|---|
| Shares in Issue | 105.34 m | Prev Close | 412.50p |
|---|
| PE Ratio | 20.618557 | Market Cap | £434.53 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.31 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.16645 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.347935 | Quick Ratio | 1.835348 |
|---|
Oxford Biomedica PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 14/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 11/10/23 | BUY | Namrata Patel | NED | 1,670 @ £2.99 | £4,993.00 |
| 27/09/23 | BUY | Michael Hayden | RES | 12,000 @ £2.94 | £35,220.00 |
| 26/09/23 | BUY | Leone Patterson | NED | 6,598 @ £2.91 | £19,167.00 |
| 26/09/23 | BUY | Dame Davies | NED | 1,000 @ £2.91 | £2,910.00 |
| 20/09/23 | BUY | Stuart Paynter | RES | 4,030 @ £2.48 | £9,998.00 |
| 20/09/23 | BUY | Stuart Henderson | NED | 1,000 @ £2.75 | £2,750.00 |
| 20/09/23 | BUY | Roch Doliveux | CH | 36,130 @ £2.74 | £99,105.00 |
| 20/09/23 | BUY | Catherine Moukheibir | RES | 7,226 @ £2.74 | £19,821.00 |
Oxford Biomedica PLC News
